Substack · M. V. Cunha's Substack · M. V. Cunha
Omada Health (OMDA): Q2 2026 Earnings Review
On Thursday, OMDA reported its Q2 results.
Since publication −23.0% α −22.0 pp vs S&P 500 · USD
US · 2 entries · 2 publications
OMDA
Omada Health, Inc.
- Entries
- 2
- Bullish
- 0
- Bearish
- 0
- First
- Jan 28, 2026
- Latest
- Aug 8, 2026
No entry states a stance.
Jan 25 – Oct 26 · per month
Full performance tracking Pro · free during launch
Alpha of every thesis on OMDA at 1, 3 and 6 months and since publication, and the full chart vs its benchmark.Free during launch: log in or sign up with your email to see it.
Sign up freeTimeline
Newest to oldest- August 2026 1 entry
- January 2026 1 entry
Substack · Karst Research
Omada Health
Ticker: OMDA. Diabetes, Hypertension, MSK, and Obesity. Point Solution.
Since publication +24.9% α +14.8 pp vs S&P 500 · USD
Prices as of the Oct 27, 2026 close. Past performance does not guarantee future results. Price-only, excluding dividends, in local currency. Data may be delayed or inaccurate. Not investment advice. How it is calculated.